Overview
Antifungal Potential of Moringa Olifera Against Otomycosis
Status:
Enrolling by invitation
Enrolling by invitation
Trial end date:
2021-12-01
2021-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed randomly into two groups. The first group will be treated with Nystatin ear drops twice daily. The second group will be treated with Moringa ear drops. patients will be examined endoscopically by the ENT specialist. patient's swabs will be isolated and analyzed by ELISA.Phase:
Early Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Deraya UniversityCollaborator:
Minia UniversityTreatments:
Carbamide Peroxide
Criteria
Inclusion Criteria:1. Otomycosis
2. ear inflammation
Exclusion Criteria:
1. tympanic membrane perforation
2. concurrent immune suppression,
3. concurrent bacterial infection.